CO6990150A1 - Combinación de compuestos derivados del ácido gálico para el tratamiento del cáncer - Google Patents

Combinación de compuestos derivados del ácido gálico para el tratamiento del cáncer

Info

Publication number
CO6990150A1
CO6990150A1 CO12236193A CO12236193A CO6990150A1 CO 6990150 A1 CO6990150 A1 CO 6990150A1 CO 12236193 A CO12236193 A CO 12236193A CO 12236193 A CO12236193 A CO 12236193A CO 6990150 A1 CO6990150 A1 CO 6990150A1
Authority
CO
Colombia
Prior art keywords
combination
cancer treatment
gallic acid
compounds derived
derived
Prior art date
Application number
CO12236193A
Other languages
English (en)
Inventor
Gomez Susana Fiorentino
Jhon Fredy Hernandez
Pinzon Claudia Patricia Urueña
Diana Castañeda
Luis Miguel Pombo
Original Assignee
Pontificia Universidad Javeriana
Fundacion Universitaria Juan N Corpas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pontificia Universidad Javeriana, Fundacion Universitaria Juan N Corpas filed Critical Pontificia Universidad Javeriana
Publication of CO6990150A1 publication Critical patent/CO6990150A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CO12236193A 2012-09-11 2012-12-28 Combinación de compuestos derivados del ácido gálico para el tratamiento del cáncer CO6990150A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2012/054703 WO2014041393A1 (es) 2012-09-11 2012-09-11 Combinación de compuestos derivados del ácido gálico para el tratamiento del cáncer

Publications (1)

Publication Number Publication Date
CO6990150A1 true CO6990150A1 (es) 2014-07-10

Family

ID=50277696

Family Applications (1)

Application Number Title Priority Date Filing Date
CO12236193A CO6990150A1 (es) 2012-09-11 2012-12-28 Combinación de compuestos derivados del ácido gálico para el tratamiento del cáncer

Country Status (5)

Country Link
US (1) US9931355B2 (es)
BR (1) BR112015005284B1 (es)
CA (1) CA2884784C (es)
CO (1) CO6990150A1 (es)
WO (1) WO2014041393A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108929202B (zh) * 2017-05-24 2021-02-19 中国人民解放军军事医学科学院生物医学分析中心 2-叔丁基-4-甲氧基苯酚制备新方法及其新晶型
WO2019078645A1 (ko) * 2017-10-18 2019-04-25 충남대학교 산학협력단 항암치료용 약학 조성물 및 이의 제조방법
CN110652529B (zh) * 2018-06-28 2021-06-08 嘉兴学院 南湖菱壳多酚提取物在制备用于抗三阴型乳腺癌药物中的用途
US12016871B2 (en) * 2020-03-20 2024-06-25 Gr Biosystems, Inc. Compositions for oral cancer or an oropharyngeal cancer
CN114230454B (zh) * 2021-12-22 2023-12-12 广西师范大学 没食子酸类天然活性成分的钙配合物及其合成方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968438A (en) * 1987-09-18 1990-11-06 Nalco Chemical Company Gallic acid as an oxygen scavenger
US5773419A (en) 1995-03-03 1998-06-30 Falcon; Juan Method of treating cancer with tannic acid
AU1774201A (en) 1999-11-19 2001-05-30 Penn State Research Foundation, The Gallotannins and ellagitannins as regulators of cytokine release
US7288273B1 (en) 2000-11-17 2007-10-30 The Penn State Research Foundation Gallotannins and ellagitannins as regulators of cytokine release
CA2527052A1 (en) 2003-05-28 2005-01-06 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Angiogenic agents from plant extracts, gallic acid, and derivatives

Also Published As

Publication number Publication date
CA2884784A1 (en) 2014-03-20
BR112015005284A2 (pt) 2017-07-04
BR112015005284B1 (pt) 2022-05-03
BR112015005284A8 (pt) 2019-08-13
US20150313925A1 (en) 2015-11-05
WO2014041393A1 (es) 2014-03-20
CA2884784C (en) 2019-01-15
US9931355B2 (en) 2018-04-03

Similar Documents

Publication Publication Date Title
IL241232A0 (en) Cancer treatment agents
CO7061081A2 (es) Derivados macrocíclicos para el tratamiento de enfermedades
PT2818482T (pt) Composição farmacêutica para o tratamento de cancro
PT2824114T (pt) Composição farmacêutica para o tratamento do cancro
EP2968348A4 (en) COMPOUNDS FOR THE TREATMENT OF CANCER
BR112014032105A2 (pt) método para o tratamento de câncer
CO6940432A2 (es) Compuestos de 1-arilcarbonilo-4-oxi-piperidina útiles para el tratamiento de enfermedades neurodegenerativas
BR112014028424A2 (pt) compostos de pirimidina para o tratamento de câncer
BR112015004548A2 (pt) inibidores de serina/treonina para tratamento de doenças hiperproliferativas
BR112014000033A2 (pt) compostos para o tratamento de dependência química
CL2015000926A1 (es) Proceso para la elaboración de compuestos para el tratamiento del cancer derivados de azetidin-1-il-metanona y compuestos intermediarios.
EP2903644A4 (en) TREATMENT OF CANCER
BR112013030370A2 (pt) compostos de quinona para tratamento de doenças mediadas por ape1
DK2892535T3 (da) Fremgangsmåde til adjuverende cancerbehandling
CO6821965A2 (es) 1-piperazino-3-fenil-indanos deuterados para el tratamiento de esquizofrenia
GB201217892D0 (en) Treatment of cancer
CO6990150A1 (es) Combinación de compuestos derivados del ácido gálico para el tratamiento del cáncer
DK2802351T3 (da) Midler til behandling af triple-negativ brystkræft
IL238592B (en) Compounds for the treatment of liver diseases
HK1204956A1 (en) Treatment of cancer
SI2892925T1 (sl) Kombinacijsko zdravljenje raka
BR112014020597A2 (pt) compostos para tratar infecção por parvovírus
EP2897607A4 (en) BETA-HYDROLASE INHIBITORS FOR THE TREATMENT OF CANCER
EP2946777C0 (en) MEDICINAL PRODUCTS FOR THE TREATMENT OF NEUROPATHIC DISEASES
GB201214877D0 (en) Compounds for treatments of tumors

Legal Events

Date Code Title Description
FG Application granted